Semaglutide in Primary Care: Benefits and Considerations for American Males with Type 2 Diabetes
Reading Time: 2 minutesIntroduction to Semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a significant therapeutic option in the management of type 2 diabetes. Its role in primary care settings is increasingly recognized, offering general practitioners a potent tool to address the complexities of diabetes management in their patients. This article explores the utility of semaglutide in primary care, focusing... Read more »